Optimizing data integration for your scientific discovery
Many Pharma companies know that they are sitting on unique data assets that could be used to discover new insights, repurpose failed drug programs, or revisit trial results to identify new segments. However, integrating data across silos
continues to be a critical challenge for researchers. Join Kim Ledoux, Thomson Reuters Director of R&D Informatics, for the latest insights on “connecting the dots” in the informatics community.